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Ischemic heart disease in patients with uremia undergoing main-
tenance hemodialysis. The 6-year cumulative incidence of is-
chemic heart disease (IHD) in 382 dialysis patients (mean age
[sEMI, 43 0.7 years) was studied. Of 101 patients with IHD,
only 39 developed symptoms following dialysis (cumulative in-
cidence, 20.8%). This group was older than those with IHD, and
in 55%, IHD occurred in the first year of dialysis. Analysis by
sex and race showed the rate of IHD in men and women to be
similar, but the rate in whites was twice that in blacks. In men,
the rate was not different from nondialysis men with similar coro-
nary risk factors, whereas in dialysis women, the rate was twice
that of a nondialysis cohort. The development of IHD did not
adversely affect long-term survival in patients without prior evi-
dence of IHD. Death from myocardial infarction occurred in 3 of
320 patients at risk. Autopsy data in 33 patients revealed 70%
stenosis of coronary arteries in 7, 4 of whom had antecedent dis-
ease. Our major conclusions are (a) the incidence of IHD during
dialysis was not different from similarly matched nondialysis
subjects; (b) the rate of IHD in dialysis women was greater than
it was in nondialysis subjects; (c) coronary artery disease only
affected long-term survival of patients with preexisting disease;
(d) autopsy data did not suggest accelerated atherosclerosis.
Maladie cardiaque ischémique chez les malades en hémodiatyse
chronique. L'incidence de Ia maladie cardiaque ischemique
(IHD) a été étudiée chez 382 malades en hémodialyse dont l'âge
moyen était de 43 [SEM] 7, sur 6 années cumulées. Parmi les
101 malades atteints d'IHD, seuls 39 ont eu des symptômes a Ia
suite de Ia dialyse (incidence cumulée 20,8%). Ce groupe était
plus que celui indemne d'IHD et, pour 55% des malades,
l'IHD est survenue au cours de la premiere année de la dialyse.
L'analyse par sexe et ethnie a montré que Ia fréquence de l'IHD
est Ia méme chez I'homme et chez Ia femme, mais qu'elle est
double chez les blancs par rapport aux noirs. Chez les hommes la
fréquence n'est pas différente de celle observée chez les individus
non dialyses ayant les mêmes facteurs de risque, alors que chez
les femmes Ia fréquence est double de celle d'une population non
dialysée. Le développement de 1'IHD n'affecte pas pejorative-
ment Ia survie a long terme des malades antérieurement in-
demnes d'THD. La mort par infarctus du myocarde est survenue
chez 3 des 320 malades exposés. Les constatations autopsiques
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chez 33 malades ont montré des sténoses coronariennes de 70%
chez 7 d'entre eux, parmi lesquels 4 avaient une atteinte an-
térieure a Ia dialyse. Nos principales conclusions sont: (a)
l'incidence de l'IHD au cours de Ia dialyse nest pas différente de
celle observée chez des sujets appariés non dialyses; (b) Ia fré-
quence de l'IHD chez les femmes dialysées est plus grande que
chez les non dialysées; (c) Ia maladie coronarienne ne modifie Ia
survie a long terme que si elle est pré-existante a Ia dialyse; (d)
les constatations autopsiques ne suggèrent pas une accélération
de Ia sclérose athéromateuse.
It is widely accepted [1-7] that patients with end-
stage renal disease have an accelerated rate of ath-
erosclerosis and an accelerated mortality from cor-
onary artery disease. But the data supporting this
premise are few and derive largely from observa-
tions that show cardiovascular disease to be the
most common cause of death in patients undergoing
maintenance hemodialysis [1-7]. These studies,
however, have not, in general, specified the type of
cardiovascular disease in question and have not
considered the fact that many dialysis patients with
cardiovascular disease have identifiable heart dis-
ease prior to entering maintenance dialysis therapy.
Lindner et al [4] have compared the incidence of de
novo ischemic heart disease (IHD) in 39 patients on
long-term hemodialysis to that of the Framingham
study population [8]. Although they reported that
their dialysis patients had an increased incidence of
IHD and a greater mortality from IHD, the small
size of their study population in contrast to the
Framingham study group raises questions about the
validity of such a comparison. Moreover, Lundin et
al [9] have recently rebutted the concept that there
is a greater incidence of heart disease in dialysis pa-
tients.
For these reasons, we evaluated the incidence of
symptomatic IHD in a large dialysis population fol-
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towed up to 7 years at the Birmingham Veterans
Hospital and at the University of Alabama Medical
Center in Birmingham. We found that there were 39
new cases of IHD in 320 patients at risk between
January of 1971 and January of 1978 and that more
than half of these cases occurred in the first year of
dialysis. The incidence of IHD was not significantly
different from that found in the male population of a
nondialysis cohort. In women, however, the rate of
IHD was equal to that of men and was twice to
three times greater than that for nondialysis sub-
jects. During the 7-year period, only 3 of 320 pa-
tients died as a result of documented myocardial in-
farction.
Methods
We reviewed the records of 382 patients under-
going maintenance hemodialysis who had been fol-
towed for intervals up to 7 years (January of 1971 to
January of 1978). The mean duration of this follow-
up was 29.5 (sEM) 1.0 months. The patients se-
lected for hemodialysis were from a cohort of 541
patients evaluated at the Birmingham VA Hospital
and at the University of Alabama Medical Center in
Birmingham between January of 1971 and Decem-
ber of 1975. During this time, few patients with dia-
betes mellitus were accepted for hemodialysis. Sim-
ilarly, patients with disseminated cancer, with se-
vere mental retardation, and with insurmountable
socioeconomic problems were excluded. Some pa-
tients failed to return for further treatment following
the initial diagnosis of end-stage renal disease and,
hence, were followed no further. Patients with a
past history of myocardial infarction or with angina
pectoris, however, were not excluded from our pro-
gram.
The mean age of this study population was 43.3
0.7 years. The group was distributed nearly evenly
between men and women (198 vs. 184) and between
whites and blacks (196 vs 186). The population was
divided into three groups. Group 1 included 62 pa-
tients with evidence of IHD prior to starting dial-
ysis. Group 2 included 39 patients who developed
symptomatic IHD following the onset of hemo-
dialysis but who had no antecedent history of IHD.
Group 3 included 281 patients who never exhibited
symptoms of IHD either before or after hemo-
dialysis. Table I presents the distribution of ages in
the entire population under study and in each of the
three subgroups.
Ischemic heart disease (IHD) was diagnosed
when typical signs and symptoms of angina pectoris
or myocardial infarction occurred. The diagnosis of
myocardial infarction was confirmed by serial elec-
trocardiographic (ECG) QRST changes, by enzyme
changes, or, in certain instances, by autopsy. Rou-
tine fractionation of the enzyme creatine phos-
phokinase was available in our institution after
1975, and an MB fraction of greater than 10 U was
considered diagnostic of myocardial injury. When a
past history of myocardial infarction or angina pec-
toris prior to the onset of IHD was obtained and
was documented in the patient's records, the pa-
tient was placed in group 1. The clinical, laboratory,
and ECG criteria used to make the diagnosis of IHD
are reviewed in detail by Logue and Hurst [10]. Left
ventricular hypertrophy (LVH) was diagnosed by
using the Estes electrocardiographic criteria [11].
Fasting plasma triglyceride concentrations were ob-
tained during the first month of hemodialysis and
were determined by standard laboratory tech-
niques. Age-related normal values were similar to
those described by Fredrickson, Levy, and Lees
[12]. Initial blood pressure represents that pressure
measured prior to the first hemodialysis. Informa-
tion regarding the distribution and range of blood
pressures in a randomly selected nondialysis group
of Birmingham area residents was provided by Dr.
Albert Oberman. Autopsies were performed on 33
of 132 patients who died during this study period.
Histologic material was reexamined by Dr. Jack
Geer of the Department of Pathology. Significant
coronary occlusion was felt to be present when
there was 70% or more narrowing of one or more
major coronary vessels. Assignment of a cause of
death was made from a review of the records of ter-
minal hospitalizations and from death certificates.
Table 1. Age distribution of 382 patients undergoing maintenance
hemodialysis
Age, years
IHDgroup 29 30to39 40to49 50to59 60 Total
Group 1 0 5 17 22 18 62
(7.8) (17) (25.3) (33.9) (16.2)
Group2 2
(2.6)
7
(10.9)
13
(13.0)
14
(16.1)
3
(5.6)
39
(10.2)
Group 3 76
(97.4)
52
(81.3)
70
(70)
51
(58.6)
32
(60.5)
281
(73.6)
Total 78 64 100 87 53 382
a Values represent absolute number of patients in each age
group. Numbers in parentheses represent the percentage distri-
bution of each category by age group. Group I are patients with
evidence of IHD prior to starting dialysis. Group 2 are 39 pa-
tients who developed symptomatic IHD following the onset of
hemodialysis but who had no prior history of IHD. Group 3 in-
clude patients with no symptoms of IHD before or after hemo-
dialysis.
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The assignment of a cause of death was simplified
somewhat because all patients were followed by us
and because most deaths occurred in the hospital
under our care.
Life-table methods were used to calculate both
the cumulative survival of the dialysis patients and
the cumulative incidence of IHD. The statistical
analysis of these data was done with the Kaplan-
Meier method for derivation of the cumulative in-
cidence [13] and the Gehan's modified Wilcoxon
test for doubly censored data for comparison of
these curves [14]. Other statistical comparisons
were made with three-way analysis of variances
with covariance for age and with linear categorial
model analysis [15]. Unless otherwise stated, all
data are expressed as mean SEM.
Results
Risk factors for ischemic heart disease: (1) Age.
Table 2 shows that the mean age for the group ac-
quiring IHD (group 2) was significantly higher than
that of the group without IHD, group 3 (P = 0.009)
when adjusted for possible racial and sex dif-
ferences. In the subset of patients between 40 and
59 years of age described in Table 3, no difference in
ages was observed between the two IHD groups.
There was, however, some evidence of a race-sex
difference with respect to age, with white women
being significantly older than white men (P =
0.004), whereas little age difference was present
between the sexes in blacks.
(2) Blood pressure. Differences in systolic and
diastolic blood pressure between groups 2 and 3
were investigated using three-way analysis of vari-
ance for race, sex, and IHD group effects, with co-
variance adjustment for age. Analysis of data in
Table 2 reveals that for mean systolic blood pres-
sure, there was no significant age adjustment. There
was, however, a significant difference between the
two racial groups. Blacks had a mean systolic pres-
sure that was 17 mm Hg higher than that of whites
(P = 0.0006). On the other hand, with respect to the
diastolic blood pressure, age adjustment was highly
significant (P <0.0001). Both a significant sex dif-
Table 2. Coronary risk factors in patients without evidence of ischemic heart disease (IHD) and in those developing symptomatic IHD
following onset of hemodialysisa
IHD status
Age
years
Race %
Black White
Initial
systolic BP
mm Hg
Initial
diastolic BP
mm Hg
Plasma triglyceride
concentration
mg/dl
LVH
%
Group 2 47.3
(39)
1.6 38.5
(39)
61.5 173 2
(32)
101 4
(37)
160 13
(34)
51.4
(37)
Group 3 40.5 0.8
(281)
53.2
(281)
46.8 166 2
(272)
99 1
(272)
144 5.2
(164)
43.8
(235)
a Values are mean SEM except for race and LVH which are percent. LVH is left ventricular hypertrophy. Numbers in parentheses
represent sample size.
Table 3. Coronary risk factors in white and black dialysis patients aged 40 to 59 yearsa
Population Age
Blood pressure5 mm Hg Plasma
triglyceride
concentration LVHInitial Initial
at risk years systolic diastolic mg/dl %
Black
Men 49±1
(25)
190±8
(25)
114±5
(25)
144±18
(13)
66.7
(21)
Women 48 0.7
(55)
177 5
(53)
103 3
(53)
134 8
(39)
65.2
(46)
White
Men 47 0.8
(30)
164 5
(30)
95 3
(30)
169 20
(15)
44.4
(27)
Women 51 1.7
(38)
153 4
(37)
85 2
(37)
150 12
(30)
31.4
(35
a Values represent mean SEM. Numbers in parentheses represent sample size. LVH is left ventricular hypertrophy.
b Mean systolic and diastolic blood pressures exceed 83% of the randomly obtained blood pressures of the white male population and
50% of those of the white female population in the Birmingham area (N = 6433). Mean systolic and diastolic blood pressures exceed
96% of the randomly obtained blood pressures of the black male and 86% of those of the black female population in the Birmingham area
(N = 3974). (Data was supplied by Dr. A. Oberman.)
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ference (P = 0.04) and a significant race by IHD
group interaction were also present. Men had a
mean diastolic blood pressure 5 mm Hg greater than
did women. In the black population, group 2 had a
significantly higher diastolic pressure than group 3.
This difference was not noted among whites.
Analysis of the subset of patients between age 40
and 59 years (Table 3) revealed that the race dif-
ference in systolic blood pressure persisted (P <
0.001) but that the age adjustment remained in-
significant. No other differences were significant.
With respect to the mean diastolic blood pressure in
this group of patients, however, the age adjustment
was significant (P = 0.01), and both race and sex
differences were also present. Blacks showed sig-
nificantly increased diastolic pressures when com-
pared to whites, and men exhibited higher diastolic
pressures than women. Interestingly, the blood
pressures in the white male patients were in the
83rd percentile of blood pressures obtained from
randomly selected white men in the Birmingham
area (N = 2,798), and those of white women sub-jects were in the 50th percentile of similarly se-
lected white women of the same area (N = 3,635).
Mean systolic and diastolic blood pressures of black
men and women exceeded a 96th percentile of ran-
domly selected black men (N = 1698) and the 86th
percentile of a similarly selected group of black
women in the Birmingham area (N = 2276).
(3) Plasma triglyceride concentration. A three-
way analysis of variance coupled with an analysis of
covariance for age was used to evaluate triglyceride
differences between groups 2 and 3. In the data pre-
sented in Table 2, the age adjustment was not signif-
icant. There was, however, a significant three-way
interaction for race, sex, and IHD (P = 0.04). The
source of this effect appeared to be the white wom-
en, in whom the group acquiring IHD had the high-
est triglyceride concentrations whereas the group
without IHD had the lowest. It is thought that this
difference might be explained partially by dif-
ferences in the disease processes causing renal fail-
ure in this group of women. We noted that women
who did not acquire IHD had a high frequency of
polycystic kidney disease as the precipitating cause
of renal failure (18.2%). The analysis of triglyceride
differences in the 40- to 59-year age group (Table 3)
was conducted in the same manner. In this subset,
neither the age adjustment nor any other effects
were significant.
(4) Left ventricular hypertrophy (LVH). The dif-
ferences in the prevalence of LVH among the race,
sex, and IHD groups was investigated by using a
linear categorical model approach, which allowed
an age adjustment. The results of the analysis of the
data in Table 2 showed that there was no significant
age effect. Blacks, however, showed a significantly
higher proportion ol LVH than did whites (P <
0.001), and men had a significantly higher propor-
tion of LVH than did women (P = 0.02). The IHD
groups when adjusted for age, race, and sex were
not significantly different with respect to the preva-
lence of LVH (Table 2). In the age group 40 to 59
years (Table 3), no significant age effect on LVH
was noted. In this group, however, a significant in-
teraction of race, sex, and IHD was noted (P =
0.01) and was caused by different patterns of LVH
in the male population. Black men without IHD had
more left ventricular hypertrophy than did those
with IHD, whereas in the white males, the highest
percentage of LVH was found in the group with
IHD (P = 0.01).
(5) Incidence of ischemic heart disease (IHD). Of
382 dialysis patients in this study, 101 had IHD. Six-
ty-two were in group 1. Because that group had evi-
dence of IHD preceding hemodialysis, it was ex-
cluded from any consideration of incidence. Thus,
of 382 patients in the study, 320 were at risk for de-
veloping de novo IHD. During the observation peri-
od, 39 patients developed IHD for the first time,
giving a 7-year incidence of 12.1% (Table 4). Of the
39 patients, 27 (69%) developed IHD by the end of
the first year of hemodialysis. Table 4 also shows
that the incidence of IHD in the overall population
Table 4. Incidence of ischemic heart disease (IHD) during 7 years of hemodialysis analyzed by age, race, and sex a
.
Population
at risk
Women
—_____________________________________
Men
Black White Total TotalBlack White Total
Overall i(ll.4)
96
J(2O.2)
69
(15.1)
165
( 5.8)
68
J?(ll.4)
87
J(9.O)
155
2?(l2.l)
320
40to5Oyears 1(12.7)
55
(23.6)
38
J(l7.2)
93
2(12.0)
25
2(26.2)
30
J(2O)
55
7(18.2)
148
a Numbers in parentheses represent percent of population. Denominators represent population at risk.
Fig. 1. A Six-year cumulative incidence of ischemic heart disease (IHD) in 320 patients with negative histories of IHD prior to hemo-
dialysis. B Six-year cumulative incidence of IHD in the white and black population at risk. Open circles are whites (N = 155); closed
circles are blacks (N = 165).
Fig. 2. A Six-year cumulative incidence of ischemic heart disease (IHD) in 148 patients at risk (aged 40 to 59 years). B Six-year
cumulative incidence of JHD in men and women aged 40 to 59 years. Open circles are men (N = 55); closed circles are women (N = 93).
at risk was greater in women than it was in men
(15.1 vs. 9.0%, 0.05 < P < 0.1) and that the in-
cidence in whites was nearly twice that in blacks (16
vs. 9%). Of 148 patients in age group 40 to 59 years,
27 (18.2%) developed IHD in 7 years. Again, the
incidence of IHD in the first year of treatment was
high, 16 of 27 patients (59.3%). The incidence of
THD in women in this group equaled that of men
and IHD was also twice as frequent in whites than
in blacks (25 vs. 12.5%). Because not all patients in
this study were at risk for the same time, Life-table
analysis was performed to determine the cumula-
tive incidence of IHD. Figure 1A and the data in
Appendix 1 reveal that for the entire population at
risk, the cumulative incidence of IHD during 6
years of hemodialysis was 20.8%. The 6-year cu-
mulative incidence of IHD in blacks (Fig. 1B) was
15.8%, whereas that of whites was 26.1% (0.05 <P
< 0.1). Figure 2A shows the 6-year cumulative in-
cidence of IHD in patients aged 40 to 59 years to be
26.9%. No significant difference in the rate of IHD
could be seen between men and women, aged 40 to 59
years, after 6 years (26.2 vs. 28.6%, P > 0.1) (Fig.
2B).
Table 5 compares the incidence of IHD observed
in the present study with that reported by Lindner
et a! [4] for the Seattle dialysis population and by
Table 5. Comparative incidence of ischemic heart disease in ages
40 to 59 years
Population
Rate per 100
Men Women
Framinghama
6-year incidence 22.6 8.5
Univ. of Alabamab
6-year cumulative 26.2 28.6
incidence
7-year incidence 20 17.2
Seattle
6-year cumulative 26.4%
incidence (all ages) (both sexes)
a Abnormal in 2 or 3: hypertension, LVH, elevated plasma
cholesterol
b Abnormal in 2 or 3: hypertension, LVH, elevated plasma tri-
glyceride
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Fig. 3. Cumulative survival of 382 hemodialysis patients. Twelve
months was 84.8%; 24 months, 74%; 36 months, 65%; 48
months, 53.3%; 60 months, 47.8%.
Kannel et a! [8] for the Framingham population. It is
apparent that the 6-year cumulative incidence seen
in our cohort is similar to that of the Seattle cohort.
Further, no difference in the incidence of IHD could
be found between our male dialysis cohort and a
nondialysis cohort of Framingham males (26.2 vs.
22.6%). Because the Framingham data represent a
6-year simple incidence, they were also compared
with a simple 7-year incidence of IHD in our cohort.
Once again, the data are similar for males. No mat-
ter how the data were analyzed, however, the in-
cidence of IHD in female dialysis patients was
greater than that seen for nondialysis women in the
Framingham group (Table 5).
Effects of ischemic heart disease on patient sur-
vival. Figure 3 shows the cumulative survival for
the 382 patients in this study. After 1 year of hemo-
dialysis, 84.8% were alive; after 2 years, 74%; after
3 years, 65%; after 4 years, 53.3%; and after 5
years, 46.8%. Figure 4 shows that patients in group
1 had a significantly worse survival rate than those
in group 3 (P <0.02). Surprisingly, survival was sig-
nificantly better (P < 0.02) in patients developing
IHD after hemodialysis (group 2) in comparison
with that of patients in group 3. Although not
shown, the same relationship of IHD to survival
was noted for the group of patients aged 40 to 59
years.
Causes of death and autopsy data. There were
132 deaths during the 7-year study period, and the
distribution of the causes of death is listed in Table
6. Cardiovascular disease was the cause of death in
40 patients (30.3%). Of these, only 13 deaths were
attributable to myocardial infarction. Pericarditis
accounted for 7, stroke for 7, cardiomyopathy for 2,
and arrhythmia for 5. Thus, the number of patients
dying from documented myocardial infarction (13
or 9.8%) was not greater than those of our patients
dying from pulmonary disease (16 or 12.1%) or from
dialysis dementia (11 or 8.3%). Furthermore, of the
Cause Number Percent
Unknown etiology 19 14.4
Cardiovascular 40 30.3
Stroke 13
Myocardial infarction 13
Pericarditis 7
Tamponade S
Arrythmia 2
Cardiomyopathy 2
Arrythmia 5
Dialysis dementia 11 8.3
Discontinued dialysis 16 12.1
Pulmonary disease 16 12.1
Pneumonia 1
Edema 6
Embolism 6
Fibrosis 2
Carcinoma 1
Sepsis 11 8.3
Miscellaneousa 19 14.4
Total 132 100
100
80
60
40
20
St
>
>
>
=
E
=0
100
St
>
>
=
a,
>
Co
E
=0
Months on dialysis
Fig. 4. Effect of ischemic heart disease on cumulative survival of
patients on maintenance hemodialysis. Open circles represent
patients with IHD prior to onset of hemodialysis (N = 62).
Closed circles are patients developing IHD following onset of
hemodialysis (N = 39). Closed triangles are patients exhibiting
no symptoms of IHD (N = 281).
12 24 36 48
Table 6. Causes of death in the hemodialysis population of the
University of Alabama Medical Center
a These include: exsanguination (3); hyperkalemia (8); star-
vation (5); hypoglycemia-lactic acidosis (1); trauma (1); breast-
carcinoma (1).
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patients dying of myocardial infarction, 10 patients
had evidence of IHD prior to the start of hemo-
dialysis. Hence, of 320 patients at risk, only 3 (1%)
died of documented myocardial infarction during a
7-year period. Of interest was the finding that at au-
topsy one of the patients had infective endocarditis
and had evidence of myocardial infarction due to
vegetative emboli rather than to atherosclerosis
(Table 7, patient 15). In 19 patients (14.4%), the
cause of death was uncertain. Of this group, 10 pa-
tients had evidence of IHD prior to the onset of he-
modialysis. Autopsy material was available for 33
of 132 patients dying in this study period (Table 7).
Coronary artery narrowing of 70% or more could be
found in only 7 patients. In 3 patients (patients 9,
20, and 23), IHD preceded dialysis and in a fourth
(patient 16), dialysis duration did not exceed 3
months, making it difficult to attribute coronary ar-
tery disease to prolonged survival with renal failure.
Severe aortic atherosclerosis could be found in only
11 patients, of whom only 2 were under age 40.
Discussion
Cardiovascular disease has been found to ac-
count for about 30% of deaths in patients with end-
stage renal disease [1—3, 5]. This observation,
coupled with the well-established finding of hyper-
tension and hypertriglyceridemia in patients with
end-stage renal disease [16—19] and the recent ob-
servation of a 20% 6-year cumulative probability of
death from coronary artery disease reported by
Lindner et al [4], has led to the view that athero-
sclerosis is accelerated in patients with end-stage
renal disease and that IHD is a major mortality risk
in patients undergoing maintenance hemodialysis.
Our analysis of 320 patients at risk for IHD in the
present study revealed that, in general, this group
was hypertensive, had an elevated plasma triglycer-
ide concentration, and had a greater than 40% in-
cidence of LVH (Tables 2 and 3). Although these
patients had an increased number of coronary risk
factors, our data do not substantiate the view that
IHD poses a significant mortality risk in all dialysis
patients. Of 132 patients in this study who died, on-
ly 13 (9.8%) died of myocardial infarction. Further,
10 of the 13 had evidence of symptomatic IHD well
before the initiation of maintenance hemodialysis.
Thus, only 3 patients dying with documented myo-
cardial infarction had no history of antecedent IHD.
Stated in another way, only 1% of the 320 patients
at risk for developing de novo IHD died of myo-
cardial infarction.
These data are in accord with observations of Ro-
guska et al [20] who found only three deaths from
myocardial infarction in 131 patients undergoing
dialysis between 1963 and 1972. Moreover, we
found that the development of IHD during the
course of hemodialysis did not affect adversely the
survival of patients with a negative history of IHD
prior to starting dialysis (Fig. 4). In fact, their sur-
vival rate was significantly better than that of pa-
tients who had not manifested findings of IHD. On
the other hand, we found the survival of patients
with evidence of IHD prior to the onset of hemo-
dialysis was significantly worse in accordance with
the observation of others [21]. Thus, we conclude
that death from myocardial infarction was not a ma-
jor risk in patients who exhibited no evidence of
IHD before the onset of hemodialysis therapy.'
The 6-year cumulative incidence of IHD in our
dialysis population at risk was 20.8%. Despite the
fact that this group was ten times larger than the
Seattle group reported by Lindner et al [4], the rates
of IHD in both groups were similar (20.8 vs. 26.4%).
Between 60 and 70% of our patients who developed
IHD following the onset of hemodialysis did so be-
fore the completion of the first year of hemo-
dialysis, which does not necessarily suggest that the
atherosclerotic process had been accelerated, but
rather that already existent, but asymptomatic, cor-
onary artery disease may have been unmasked by
the hemodynamically stressful hemodialysis proce-
dure. If our view is correct, nearly half the new epi-
sodes of IHD seen following the onset of hemo-
dialysis might in actuality represent preexistent dis-
ease, and thus perhaps the differences reported here
and by others [4] between the incidence of IHD in
patients with end-stage renal disease and in non-
dialysis subjects might well be reduced.
We realize that the systemic effects of uremia,
and the use of hemodialysis with its attendant he-
modynamic effects, in part, may make it difficult to
find a truly matched nondialysis population to serve
as a basis for comparison. Moreover, in the absence
of data regarding smoking and body habitus, we are
unable to evaluate the relative influence of these
factors in the dialysis and nondialysis populations.
Although we recognize these limitations, and that
there are differences between the racial distribution
in our group and the Framingham population, we
' Between 1971 and 1978, only one patient with symptomatic
IHD underwent coronary artery bypass. Thus, in this study, the
natural history of IHD was not altered by surgical intervention.
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necrosis
19 30 WM 13 Group 3 D.C. dialysis HBP
20 76 WM 2 Group I Puim. fibrosis CGN
21 44WF
22 59WF
23 55WM
24 65WF
9 Group 2 Dialysis Unk
dementia
6 Group 3 Dialysis CGN
dementia
20 Group 1 MI
29 Group 2 Dialysis
dementia
25 5OBM 51 Group3 Pulm.embolus CGN
12 Group 3 Arrythmia
68 Group 3 Sudden
death
42 Group 3 Arrythmia
48 Group 3 Arrythmia
++ 0 Metastatic myocardial
calcifications
0
0 60% occlusion AV nodal artery;
calcification AV node
+ 0 0 0 No coronary artery pathology
+ 0 0 0 No coronary artery pathology
+ 0 0 0 No coronary artery pathology
+ 0 0 0
+ 0 0 0 AV and SA nodes normal
+ + 0 +
0 0 0
+ 0 0 0 Minimal muscular hyperplasia
of small coronary arteries
++ 0 0 0 Amyloidosis of coronary vessels
and L. atrial endocardium
+ 0 0 0
+ 0 0 0 Aspergillosis of myocardium
+ + + + + Recent MI; calcified microemboli
small coronary vessels. No
chest pain until MI.
+ 0 + 0 Severe arteriosclerotic iliac &
0 0 0
0 0 0
0 0 0 Focal myocardial calcification
+ + + + Focal myocardial calcification;
old scattered miliary infarcts
++ 0 0 0
+ 0 0 0
+ 0 Old MI; fresh infarcts. AV and
SA nodal arteries normal
0 0 Fibrosis of papillary muscles
0 0 Calcific aortic valvulitis;
coronary ostia patent patchy
myocardial fibrosis
++ + + + Myocarditis; pericarditis
0 0 0 Myocardial fibrosis, mild
+ + 0 0 0 Moderate myocardial fibrosis
0 0 0 Extensive subendocardial calci-
fication near AV node
+ + 0 0 0 Minimal calcification LAD
++ 0 + 0 Extensive M1;caseatinggranu-
lomas in myocardium, no chest
pain until MI
++ 0 0 0
0 0 0 Necrosis & calcification of mitral
valve ring; multiple calcific
microemboli.
Table 7. Correlation of clinical and postmortem findings of ischeniic heart disease (IHD) in 33 patients who underwent maintenance
hemodialysis
Age,
race,
.Duration
of
dialysis IHD
Cause
of
Cause of
renal
Athero-
sclerosis
Coronary artery
atherosclerosis
 70% narrowingd
-—
Patient sex months status deaths failure' aortae RCA LAD LCA Comments
0 0
+ 0 0
+ 0 0
2 44WF
3 4OBF
4 64WM
5 42BM
6 47BF
7 36BM
8 52BM
9 59BF
10 17WM
11 5OBF
12 59BF
13 52WF
14 52WF
15 36BM
16 58BF CGN
cerebral vessels
Cortical
necrosis
CGN
++ 0
+ 0
+ 0
26 54WM
27 64WF
28 44BM
29 45WM
30 3SWF
31 S6WM
Diabetes
mellitus
CIN
HBP
CON
Diabetes
mellitus
HBP
25 Group 3 Sepsis
34 Group 2 Ml, Tbc
32 66 BM 27 Group 3 Broncho- Unk
pneumonia
33 56 BM 30 Group 3 Sepsis HBP
a D.C. dialysis is discontinued dialysis; MI, myocardial infarction; SBE, subacute bacterial endocarditis; Tbc, tuberculosis.
CGN = chronic glomerulonephritis; HBP = hypertension; CIN = chronic intersitial nephritis.
Mild is moderate, +; severe, ++.
d RCA = right coronary artery; LAD = left anterior descending artery; LCA = left circumflex artery.
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have chosen, as did Lindner [4], to compare our re-
suits to the Framingham study, because the com-
pleteness of this study provides the most reasonable
comparison. It should be noted that our patients
had two or three of the following important coro-
nary risk factors, hypertension, LVH, or hyper-
triglyceridemia, whereas those subjects in the
Framingham study to whom we compared our pa-
tients differed in that plasma cholesterol was used
as an index of plasma lipid concentration. In this
regard, studies by Carlson and Bottiger [22] and
Brown, Kinch, and Doyle [23] have shown that a
parallel relationship exists for the prevalence of
IHD and either plasma triglyceride or serum choles-
terol concentration. Gotto et a! [24] recently have
shown a direct relationship between either plasma
triglyceride or plasma cholesterol concentration
and the severity of coronary artery disease. Thus,
although we argue that the basis for our comparison
is reasonable, we recognize the possibility that our
results might have been different had measurements
of cholesterol been made.
In our study, no difference was noted among men
when either simple incidence or cumulative in-
cidence of IHD was compared (Table 5). On the
other hand, no matter what the basis of comparison,
women with end-stage renal disease had a two- to
three-fold greater incidence of IHD when compared
to women in the Framingham study (Tables 4 and 5,
Fig. 2B). Moreover, irrespective of race, the male
predominance of IHD usually seen in the general
population was not observed in the dialysis popu-
lation. This is noteworthy because data from the
Framingham study have shown that rates of IHD in
women did not reach those of men until age 68 years
[25]. It would appear from these data that the in-
cidence of IHD in women with end-stage renal dis-
ease was increased.
It is not clear why the incidence of IHD in women
was accelerated. Although the white women were
significantly older than white men (Table 3), there
was no difference in the ages of white men and
women who developed IHD. The mean age for both
groups was 47 years. No differences could be found
between the ages of black men or women (Table 3).
Moreover, the blood pressure and prevalence of
LVH in women were lower than in men (Tables 2
and 3). Measurements of ponderal indices and
smoking habits were not obtained, and thus their
influence on the differing rates of IHD seen in men
and women cannot be measured. Analysis of plas-
ma triglyceride concentration, however, revealed
that white women acquiring IHD had the highest tn-
glyceride concentrations. Although it would be
tempting to speculate on the reasons for the in-
creased incidence of IHD in women, and to consid-
er the effects of renal-failure-induced gonadal hor-
mone abnormalities on this process, the data in our
study do not allow us to address this question fur-
ther.
The incidence of IHD was consistently greater in
whites than in blacks (Fig. 1B, Table 4). This obser-
vation seemed surprising because blacks had signif-
icantly higher blood pressures and significantly
more LVH than did whites. Again, we are unable to
analyze the potential effects of smoking and body
habitus on these differences. Nevertheless, the find-
ing is in accord with several epidemiologic analyses
of IHD in nondialysis populations that reveal the
prevalence of IHD in blacks to be less than that of
whites [26—27]. Thus, unlike the changes in the sex
distribution of IHD disease seen in our dialysis pop-
ulation, no such changes were noted in its racial dis-
tribution.
Coronary artery lumenal narrowing of 70% or
more was found at autopsy in only 7 of 33 patients
dialyzed for 2 to 68 months (Table 7). In 3 patients,
IHD preceded hemodialysis, and in a fourth, the
short duration of dialysis (less than 3 months) sug-
gested that the IHD may also have preceded hemo-
dialysis. Similarly, severe aortic atherosclerosis
was found in only 11 of the 33 patients who under-
went autopsy. Only 2 of these patients were under
40 years of age. Our autopsy data, although limited,
do not support the concept that atherosclerosis is
accelerated in patients undergoing chronic hemo-
dialysis.
Summary. We conclude that the incidence of IHD
in men undergoing hemodialysis for end-stage renal
disease is not greater than that seen in a nondialysis
population of men with similar risk factors. In con-
trast, we have found the rate of IHD in women with
end-stage renal disease to be accelerated when
compared to similar nondialysis subjects. Our data
also suggest that during the 7 years of hemodialysis
IHD does not represent a major mortality risk in
patients who have not had symptoms of IHD prior
to hemodialysis, although it does pose a significant
mortality risk in patients with evidence of estab-
lished coronary artery disease prior to the onset of
dialysis.
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Appendix
Appendix 1. Probability of developing ischemic heart disease (IHD) during hemodialysisa
No. of patients Probability of
Months of dialysis' entering Censored No. developing IHD developing IHD Exact SEM
0 320 0 4 0.0125 0.0062
316 7 1 0.0156 0.0069
2 308 6 4 0.0284 0.0093
3 298 9 2 0.0349 0.0103
4 287 15 1 0.0383 0.0108
5 271 6 2 0.0454 0.0118
6 263 5 1 0.0490 0.0123
7 257 2 3 0.0601 0.0137
8 252 6 1 0.0639 0.0142
10 239 3 2 0.0716 0.0151
12 224 3 1 0.0757 0.0156
13 220 5 2 0.0841 0.0165
15 209 3 1 0.0885 0.0170
16 205 3 1 0.0930 0.0175
17 201 4 2 0.1020 0.0185
19 192 5 1 0.1067 0.0189
21 181 4 1 0.1116 0.0195
24 170 1 1 0.1168 0.0200
25 168 5 1 0.1221 0.0206
33 120 2 1 0.1294 0.0217
34 117 7 1 0.1369 0.0227
36 103 6 1 0. 1452 0.0240
42 63 3 1 0.1588 0.0272
52 36 3 1 0.1822 0.0351
53 32 2 1 0.2077 0.0423
81 3 0 1 0.4718 0.2177
a Statistical analysis was by method of Kaplan and Meier [13].
b Entries are recorded only when an event (new episode of IHD) occurred.
Last patient exited study at 84 months.
Appendix 2. Probability of developing ischemic heart disease (IHD) during hemodialysis: age, 40 to 59 years
No. of patients Probability of
Months of dialysis enteringa Censored No. developing IHD developing IHD Exact SEM
0 148 1 2 0.0135 0.0095
145 3 1 0.0203 0.01 16
2 141 4 3 0.0411 0.0164
3 134 5 1 0.0483 0.0178
5 125 1 2 0.0635 0.0205
6 122 2 1 0.0712 0.0217
7 119 0 3 0.0946 0.0250
8 116 3 1 0.1024 0.0260
10 111 0 2 0.1186 0.0279
13 103 2 2 0.1357 0.0299
15 98 0 1 0.1445 0.0308
16 97 1 1 0.1533 0.0318
19 92 1 1 0.1625 0.0327
21 87 2 1 0.1721 0.0337
24 79 1 1 0.1826 0.0349
34 53 1 1 0. 1980 0.0375
42 30 1 1 0.2248 0.0448
53 18 1 1 0.2678 0.0595
81 2 0 1 0.6339 0.2613
a Last patient exited study at 84 months.
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Appendix 3. Probability of developing ischemic heart disease (IHD) during hemodialysis: Black population
No. of patients Probability of
Months of dialysis enteringa Censored No. developing IHD developing IHD Exact SCM
0 165 0 1 0.0060 0.0060
2 159 5 2 0.0185 0.0106
3 152 6 1 0.0250 0.0123
4 145 5 1 0.0317 0.0139
5 139 4 1 0.0387 0.0155
6 134 3 1 0.0458 0.0169
7 130 0 1 0.0532 0.0183
12 120 1 1 0.0611 0.0198
13 118 1 1 0.0690 0.0212
16 112 0 1 0.0773 0.0225
19 105 2 1 0.0861 0.0240
21 97 1 1 0.0955 0.0255
36 60 5 1 0.1106 0.0292
52 19 2 1 0.1574 0.0533
a Last patient exited study at 77 months.
Appendix 4. Probability of developing ischemic heart disease (IHD) during hemodialysis: White population
No. of patients Probability of
Months of dialysis enteringa Censored No. developing IHD developing IHD Exact SCM
0 155 1 3 0.0193 0.0110
151 2 1 0.0258 0.0127
2 148 1 2 0.0390 0.0156
3 145 3 1 0.0456 0.0168
5 131 2 1 0.0529 0.0182
7 126 2 2 0.0679 0.0208
8 122 4 1 0.0756 0.0220
10 114 2 2 0.0918 0.0244
13 101 4 1 0.1008 0.0257
IS 95 2 1 0.1102 0.0271
17 89 1 2 0.1302 0.0300
24 79 1 1 0.1412 0.0316
25 77 2 1 0.1524 0.0331
33 53 1 1 0.1684 0.0361
34 51 3 1 0.1847 0,0389
42 31 1 1 0.2110 0.0457
53 16 1 1 0.2603 0.0642
81 3 0 1 0.5068 0.2065
a Last patient exited study at 84 months.
Appendix 5. Probability of developing ischemic heart disease (IHD) during hemodialysis: Women, age 40 to 59 years
No. of patients Probability of
Months of dialysis enteringa Censored No. developing IHD developing IHD Exact SCM
0 93 1 2 0.0215 0.0150
1 90 1 1 0.0323 0.0183
2 88 4 3 0.0653 0.0258
5 80 1 2 0.0887 0.0299
10 74 0 1 0.1010 0.0320
13 70 1 2 0.1267 0.0358
16 66 1 1 0.1399 0.0377
19 63 1 1 0.1536 0.0395
21 59 2 1 0.1679 0.0413
24 53 0 1 0.1836 0.0434
53 8 1 1 0.2857 0.1028
a Last patient exited study at 84 months.
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Appendix 6. Probability of developing ischemic heart disease (IHD) during hemodialysis: Men, age 40 to 59 years
Months of dialysis
No. of patients
entering Censored No. developing IHD
Probability of
developing IHD Exact SEM
0 55 2 0 0.0000 0.00
3 53 4 1 0.0188 0.01868
6 45 2 1 0.0406 0.0282
7 42 0 3 0.1091 0.0462
8 39 1 1 0.1320 0.0504
10 37 0 1 0.1554 0.0542
15 32 0 1 0.1818 0.0586
34 21 0 1 0.2208 0.0676
42 19 1 1 0.2618 0.0755
81 1 0 1 1.000 0.0000
Reprint requests to Dr. S. G. Rostand, Division of Nephrolo-
gy, Department of Medicine, University of Alabama Medical
Center, Birmingham, Alabama 35294, USA
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